<html><head><link rel="stylesheet" href="https://unpkg.com/mvp.css"></head><title>Availability of Medicines</title><body><h1>Availability of Medicines</h1><p style="text-align:justify">Medicines for Vector Borne Diseases (VBDs) (including Malaria and Dengue) under National Vector Borne Disease Control Programme (NVBDCP) are available at all levels of interventions including Government Hospitals and Dispensaries.  The drugs for treatment of malaria are provided free of cost to States/ Union Territories (UTs). The drugs provided are Artemisinin Combination Therapy with SulphadoxinePyremethamine (ACT-SP)(0-1 Years), ACT-SP (1-4 Years) packs, ACT-SP (5-8 Years) packs, ACT-SP (9-14 Years) packs, ACT-SP (for Adults) packs, Artesunate Injections (vials), Diethylcarbamazine Citrate (DEC) Tablets (in numbers) which are available in sufficient quantity. There is no specific drug for treatment of Dengue, however, kits are provided for   diagnosis of dengue.  </p>
<p style="text-align:justify"> In respect of seasonal influenza A (H1N1)/Swine flu,  Oseltamivir is the drug recommended by the World Health Organisation (WHO) for treatment of seasonal Influenza A (H1N1) in capsule/tablet and suspension form,  and is made  available  free of cost by  the State Government  in all Government hospitals in Madhya Pradesh.  As per data received from State </p>
<p style="text-align:justify">Surveillance Unit (SSU) of Integrated Disease Surveillance Programme (IDSP), details of medicine provided by State for distribution to the patients are as under:</p>
<p style="text-align:justify">Year</p>
<p style="text-align:justify">Quantity of medicines provided</p>
<p style="text-align:justify">2016</p>
<p style="text-align:justify">13580</p>
<p style="text-align:justify">2017</p>
<p style="text-align:justify">25069</p>
<p style="text-align:justify">2018</p>
<p style="text-align:justify">92424</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify"> </p>
<p style="text-align:justify"> </p>
<p style="text-align:justify"> </p>
<p style="text-align:justify"> </p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">Under National Leprosy Eradication Programme (NLEP) with the support of WHO, free of cost Multi Drug Therapy (MDT) is being provided to all States/UTs including Madhya Pradesh. The details of MDT provided to Madhya Pradesh during last three years are  as under:-</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">Year</p>
<p style="text-align:justify">Multi Bacillary Adult (MBA)</p>
<p style="text-align:justify">Multi Bacillary Child</p>
<p style="text-align:justify">(MBC)</p>
<p style="text-align:justify">Pauci Bacillary Adult (PBA)</p>
<p style="text-align:justify">Pauci</p>
<p style="text-align:justify">Bacilary</p>
<p style="text-align:justify">Child (PBC)</p>
<p style="text-align:justify">Clofazimine 100mg</p>
<p style="text-align:justify">Clofazimine</p>
<p style="text-align:justify">50 mg</p>
<p style="text-align:justify">2016-17</p>
<p style="text-align:justify">44472</p>
<p style="text-align:justify">2016</p>
<p style="text-align:justify">13924</p>
<p style="text-align:justify">1146</p>
<p style="text-align:justify">0</p>
<p style="text-align:justify">0</p>
<p style="text-align:justify">2017-18</p>
<p style="text-align:justify">47898</p>
<p style="text-align:justify">1998</p>
<p style="text-align:justify">13956</p>
<p style="text-align:justify">1296</p>
<p style="text-align:justify">24000</p>
<p style="text-align:justify">0</p>
<p style="text-align:justify">2018-19</p>
<p style="text-align:justify">31530</p>
<p style="text-align:justify">1728</p>
<p style="text-align:justify">8064</p>
<p style="text-align:justify">678</p>
<p style="text-align:justify">8500</p>
<p style="text-align:justify">0</p>
<p style="text-align:justify">*MBA, MBC, PBA, PBC all in Blister Clander pack (BCP)</p>
<p style="text-align:justify">(Clofazimine 50 &#038; 100 mg capsules, in reaction cases).</p>
<p style="text-align:justify">The Minister of State (Health and Family Welfare), ShAshwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">*****</p>
<p style="text-align:justify">
</body></html>